Podiatrists in Bloomsburg, PA Accepting Medicare
4 Podiatrists found. Showing 1 - 4
 Karen Campbell, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 410 Glenn Ave, Suite 201, Bloomsburg, PA 17815 Phone: 570-387-2202 |
Dr. David J. Portonova, D.P.M Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 6850 Lows Rd Ste 316, Bloomsburg, PA 17815 Phone: 570-387-2202 Fax: 570-387-2203 |
 Portonova Foot And Ankle Specialists Llc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 6850 Lows Rd Ste 316, Bloomsburg, PA 17815 Phone: 570-387-2202 Fax: 570-387-2203 |
Karen Campbell, Dpm Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 410 Glenn Ave, Suite 201, Bloomsburg, PA 17815 Phone: 570-387-2022 Fax: 570-387-2203 |
News Archive
Fundamental flaws in many medical studies must be fixed in order to catch signs of harm
Only by analyzing results using a statistical method that considers several factors at once - for instance, overall heart attack risk, rather than just individual risk factors such as age - will researchers truly be able to see how the risks and benefits of a treatment vary from patient to patient, the study suggests.
Severe COVID-19 pneumonia patients with high ferritin show better outcomes after steroid treatment
During the entire pandemic, physicians treating patients with severe Covid-19 pneumonia continuously looked for hints and signs on what may enable patients to have better outcomes.
Repros Therapeutics amends its existing license for Proellex
Repros Therapeutics today announced that the Company has entered into an amendment with the National Institutes of Health (NIH) to its existing exclusive license for Proellex® that revises the existing milestones and dates for performance to provide additional time to lift the current clinical hold on Proellex or select a second generation molecule for further development from the family of anti-progestational agents covered by the license.
Anacor Pharmaceuticals initiates AN2728, AN2898 Phase 2 trial in mild-to-moderate atopic dermatitis
Anacor Pharmaceuticals announced today that the first patient has been dosed in a Phase 2 trial of AN2728 and AN2898 to determine safety, tolerability and efficacy of the two compounds for the topical treatment of mild-to-moderate atopic dermatitis.
› Verified 5 days ago
Physical Therapists
Chiropractors
Speech-Language Pathologists
Optometrists
Audiologists
Occupational Therapists
Podiatrists